Literature DB >> 17205241

Medium-term survival without haematopoietic stem cell transplantation in a case of IPEX: insights into nutritional and immunosuppressive therapy.

Andrea Taddio1, Elena Faleschini, Erica Valencic, Marilena Granzotto, Alberto Tommasini, Loredana Lepore, Marino Andolina, Egidio Barbi, Alessandro Ventura.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17205241     DOI: 10.1007/s00431-006-0395-6

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  10 in total

1.  Manifestations and linkage analysis in X-linked autoimmunity-immunodeficiency syndrome.

Authors:  P J Ferguson; S H Blanton; F T Saulsbury; M J McDuffie; V Lemahieu; J M Gastier; U Francke; S M Borowitz; J L Sutphen; T E Kelly
Journal:  Am J Med Genet       Date:  2000-02-28

2.  A long-term survivor with the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.

Authors:  I Kobayashi; N Kawamura; M Okano
Journal:  N Engl J Med       Date:  2001-09-27       Impact factor: 91.245

3.  Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation.

Authors:  O Baud; O Goulet; D Canioni; F Le Deist; I Radford; D Rieu; S Dupuis-Girod; N Cerf-Bensussan; M Cavazzana-Calvo; N Brousse; A Fischer; J L Casanova
Journal:  N Engl J Med       Date:  2001-06-07       Impact factor: 91.245

4.  The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3.

Authors:  C L Bennett; J Christie; F Ramsdell; M E Brunkow; P J Ferguson; L Whitesell; T E Kelly; F T Saulsbury; P F Chance; H D Ochs
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

5.  Successful use of the new immune-suppressor sirolimus in IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome).

Authors:  Lutz Bindl; Troy Torgerson; Lucia Perroni; Nelly Youssef; Hans D Ochs; Olivier Goulet; Frank M Ruemmele
Journal:  J Pediatr       Date:  2005-08       Impact factor: 4.406

6.  JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome.

Authors:  T A Chatila; F Blaeser; N Ho; H M Lederman; C Voulgaropoulos; C Helms; A M Bowcock
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

Review 7.  Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome.

Authors:  R S Wildin; S Smyk-Pearson; A H Filipovich
Journal:  J Med Genet       Date:  2002-08       Impact factor: 6.318

Review 8.  Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis.

Authors:  Eleonora Gambineri; Troy R Torgerson; Hans D Ochs
Journal:  Curr Opin Rheumatol       Date:  2003-07       Impact factor: 5.006

9.  A new case of IPEX receiving bone marrow transplantation.

Authors:  E Mazzolari; C Forino; M Fontana; C D'Ippolito; A Lanfranchi; E Gambineri; H Ochs; R Badolato; L D Notarangelo
Journal:  Bone Marrow Transplant       Date:  2005-05       Impact factor: 5.483

10.  X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy.

Authors:  R S Wildin; F Ramsdell; J Peake; F Faravelli; J L Casanova; N Buist; E Levy-Lahad; M Mazzella; O Goulet; L Perroni; F D Bricarelli; G Byrne; M McEuen; S Proll; M Appleby; M E Brunkow
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

  10 in total
  9 in total

1.  Stable hematopoietic cell engraftment after low-intensity nonmyeloablative conditioning in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.

Authors:  Lauri M Burroughs; Troy R Torgerson; Rainer Storb; Paul A Carpenter; David J Rawlings; Jean Sanders; Andrew M Scharenberg; Suzanne Skoda-Smith; Janet Englund; Hans D Ochs; Ann E Woolfrey
Journal:  J Allergy Clin Immunol       Date:  2010-11       Impact factor: 10.793

Review 2.  Gastrointestinal Manifestations and Complications of Primary Immunodeficiency Disorders.

Authors:  Shradha Agarwal; Charlotte Cunningham-Rundles
Journal:  Immunol Allergy Clin North Am       Date:  2019-02       Impact factor: 3.479

Review 3.  Recent advances in transplantation for primary immune deficiency diseases: a comprehensive review.

Authors:  M Teresa de la Morena; Robert P Nelson
Journal:  Clin Rev Allergy Immunol       Date:  2014-04       Impact factor: 8.667

4.  A novel mutation and unusual clinical features in a patient with immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome.

Authors:  Keun Wook Bae; Bo Eun Kim; Jin-Ho Choi; Joo Hoon Lee; Young Seo Park; Gu-Hwan Kim; Han Wook Yoo; Jong Jin Seo
Journal:  Eur J Pediatr       Date:  2011-10-07       Impact factor: 3.183

Review 5.  FOXP3: genetic and epigenetic implications for autoimmunity.

Authors:  Hiroto Katoh; Pan Zheng; Yang Liu
Journal:  J Autoimmun       Date:  2013-01-11       Impact factor: 7.094

Review 6.  Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency.

Authors:  Shradha Agarwal; Lloyd Mayer
Journal:  Clin Gastroenterol Hepatol       Date:  2013-03-13       Impact factor: 11.382

7.  Late-onset of immunodysregulation, polyendocrinopathy, enteropathy, x-linked syndrome (IPEX) with intractable diarrhea.

Authors:  Daniele Zama; Ilaria Cocchi; Riccardo Masetti; Fernando Specchia; Patrizia Alvisi; Eleonora Gambineri; Mario Lima; Andrea Pession
Journal:  Ital J Pediatr       Date:  2014-10-18       Impact factor: 2.638

8.  Immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome: a paradigm of immunodeficiency with autoimmunity.

Authors:  Federica Barzaghi; Laura Passerini; Rosa Bacchetta
Journal:  Front Immunol       Date:  2012-07-31       Impact factor: 7.561

9.  Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study.

Authors:  Federica Barzaghi; Laura Cristina Amaya Hernandez; Benedicte Neven; Silvia Ricci; Zeynep Yesim Kucuk; Jack J Bleesing; Zohreh Nademi; Mary Anne Slatter; Erlinda Rose Ulloa; Anna Shcherbina; Anna Roppelt; Austen Worth; Juliana Silva; Alessandro Aiuti; Luis Murguia-Favela; Carsten Speckmann; Magda Carneiro-Sampaio; Juliana Folloni Fernandes; Safa Baris; Ahmet Ozen; Elif Karakoc-Aydiner; Ayca Kiykim; Ansgar Schulz; Sandra Steinmann; Lucia Dora Notarangelo; Eleonora Gambineri; Paolo Lionetti; William Thomas Shearer; Lisa R Forbes; Caridad Martinez; Despina Moshous; Stephane Blanche; Alain Fisher; Frank M Ruemmele; Come Tissandier; Marie Ouachee-Chardin; Frédéric Rieux-Laucat; Marina Cavazzana; Waseem Qasim; Barbarella Lucarelli; Michael H Albert; Ichiro Kobayashi; Laura Alonso; Cristina Diaz De Heredia; Hirokazu Kanegane; Anita Lawitschka; Jong Jin Seo; Marta Gonzalez-Vicent; Miguel Angel Diaz; Rakesh Kumar Goyal; Martin G Sauer; Akif Yesilipek; Minsoo Kim; Yesim Yilmaz-Demirdag; Monica Bhatia; Julie Khlevner; Erick J Richmond Padilla; Silvana Martino; Davide Montin; Olaf Neth; Agueda Molinos-Quintana; Justo Valverde-Fernandez; Arnon Broides; Vered Pinsk; Antje Ballauf; Filomeen Haerynck; Victoria Bordon; Catharina Dhooge; Maria Laura Garcia-Lloret; Robbert G Bredius; Krzysztof Kałwak; Elie Haddad; Markus Gerhard Seidel; Gregor Duckers; Sung-Yun Pai; Christopher C Dvorak; Stephan Ehl; Franco Locatelli; Frederick Goldman; Andrew Richard Gennery; Mort J Cowan; Maria-Grazia Roncarolo; Rosa Bacchetta
Journal:  J Allergy Clin Immunol       Date:  2017-12-11       Impact factor: 10.793

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.